Abacavir/Lamivudine/Zidovudine
Abacavir/lamivudine/zidovudine
All Updates
Description:
Abacavir/lamivudine/zidovudine (INNs, trade name Trizivir) is a pharmaceutical treatment for HIV infection. It is a fixed dose combination of three reverse transcriptase inhibitors patented by GlaxoSmithKline and now marketed by its joint venture with Pfizer, ViiV Healthcare:
It is indicated in the treatment of AIDS/HIV.
The combination of drugs is helpful in that it helps to reduce HIV's resistance (through mutation) to the drugs individually. Of the three, AZT and ABC have passed out of United States patent protection.
Read More
- abacavir ("ABC")
- lamivudine ("3TC")
- zidovudine ("AZT")
It is indicated in the treatment of AIDS/HIV.
The combination of drugs is helpful in that it helps to reduce HIV's resistance (through mutation) to the drugs individually. Of the three, AZT and ABC have passed out of United States patent protection.
Read More
Posting your question. Please wait!...No messages found
Suggested Pages
Tell your friends >
about this page
about this page
Create a new Page
for companies, colleges, celebrities or anything you like.Get updates on MyPage.
Create a new Page
Find your friends
Find friends on MyPage from
© 2013 Rediff.com -